Pneumonia News

Among patients hospitalized with SARS-CoV-2 community-acquired pneumonia, those with vs. without cardiovascular complications had a heightened mortality rate, according to results published in CHEST.

Severe obstructive sleep apnea raised the risk for hospital admittance with pneumonia and any infections compared with individuals who have normal breathing during sleep, according to results published in CHEST.

Patients in the ICU for pneumonia with vs. without alcohol misuse faced heightened odds for mortality, mechanical ventilation and extended hospital stays, according to results published in Annals of the American Thoracic Society.

Fewer patients with community-acquired pneumonia using corticosteroids vs. standard care needed mechanical ventilation, but mortality rates did not differ between both groups, according to study results published in CHEST.

A long-acting muscarinic antagonist plus long-acting beta agonist (LABA) was linked to fewer COPD exacerbations and pneumonia hospitalizations vs. an inhaled corticosteroid and LABA, according to results published in JAMA Internal Medicine.

The FDA has approved IV sulbactam-durlobactam to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex.

The FDA on Wednesday approved the world’s first vaccine against respiratory syncytial virus, which followed years of failed attempts by scientists to develop one.

A nurse-created algorithm helped determine which patients with multiple myeloma exhibited the highest risk for pneumonia, according to study results.

The FDA has granted 510(k) clearances to seven triage and notification findings of varying conditions on chest X-ray and head CT images, according to a manufacturer-issued press release.

A machine-learning model showed excellent discriminative ability in predicting 30-day mortality in patients with community-acquired pneumonia, according to study results published in CHEST.